SciCombinator

Discover the most talked about and latest scientific content & concepts.

Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis

OPEN The New England journal of medicine | 4 Oct 2018

O Van Der Meeren, M Hatherill, V Nduba, RJ Wilkinson, M Muyoyeta, E Van Brakel, HM Ayles, G Henostroza, F Thienemann, TJ Scriba, A Diacon, GL Blatner, MA Demoitié, M Tameris, M Malahleha, JC Innes, E Hellström, N Martinson, T Singh, EJ Akite, A Khatoon Azam, A Bollaerts, AM Ginsberg, TG Evans, P Gillard and DR Tait
Abstract
A vaccine to interrupt the transmission of tuberculosis is needed.
Tweets*
473
Facebook likes*
5
Reddit*
0
News coverage*
26
Blogs*
1
SC clicks
0
Concepts
-
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com